サワイグループホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/06/14 | 3,800 | 3,910 | 3,785 | 3,865 | -75 | -1.9% | 242,500 |
2022/06/13 | 3,915 | 3,965 | 3,915 | 3,940 | -10 | -0.3% | 100,300 |
2022/06/10 | 3,940 | 3,960 | 3,910 | 3,950 | +20 | +0.5% | 128,000 |
2022/06/09 | 3,940 | 3,985 | 3,930 | 3,930 | -10 | -0.3% | 120,900 |
2022/06/08 | 3,870 | 3,960 | 3,870 | 3,940 | +70 | +1.8% | 122,500 |
2022/06/07 | 3,860 | 3,890 | 3,835 | 3,870 | +20 | +0.5% | 85,200 |
2022/06/06 | 3,820 | 3,870 | 3,815 | 3,850 | +30 | +0.8% | 97,700 |
2022/06/03 | 3,825 | 3,870 | 3,810 | 3,820 | +15 | +0.4% | 119,600 |
2022/06/02 | 3,845 | 3,845 | 3,780 | 3,805 | -50 | -1.3% | 90,200 |
2022/06/01 | 3,840 | 3,890 | 3,830 | 3,855 | +55 | +1.4% | 105,100 |
2022/05/31 | 3,855 | 3,900 | 3,800 | 3,800 | -80 | -2.1% | 215,100 |
2022/05/30 | 3,850 | 3,885 | 3,830 | 3,880 | +35 | +0.9% | 287,200 |
2022/05/27 | 3,880 | 3,885 | 3,790 | 3,845 | -35 | -0.9% | 158,900 |
2022/05/26 | 3,850 | 3,890 | 3,845 | 3,880 | +10 | +0.3% | 121,200 |
2022/05/25 | 3,905 | 3,925 | 3,865 | 3,870 | -30 | -0.8% | 84,100 |
2022/05/24 | 3,910 | 3,940 | 3,885 | 3,900 | -75 | -1.9% | 82,100 |
2022/05/23 | 3,965 | 4,005 | 3,940 | 3,975 | +40 | +1% | 78,700 |
2022/05/20 | 3,900 | 3,950 | 3,885 | 3,935 | +35 | +0.9% | 99,300 |
2022/05/19 | 3,815 | 3,910 | 3,815 | 3,900 | +30 | +0.8% | 123,000 |
2022/05/18 | 3,900 | 3,935 | 3,850 | 3,870 | -35 | -0.9% | 171,600 |
2022/05/17 | 3,880 | 3,985 | 3,870 | 3,905 | +95 | +2.5% | 169,200 |
2022/05/16 | 3,945 | 3,950 | 3,800 | 3,810 | -95 | -2.4% | 170,100 |
2022/05/13 | 3,800 | 3,925 | 3,760 | 3,905 | +70 | +1.8% | 287,000 |
2022/05/12 | 4,030 | 4,070 | 3,835 | 3,835 | -355 | -8.5% | 332,200 |
2022/05/11 | 4,350 | 4,350 | 4,160 | 4,190 | +50 | +1.2% | 126,300 |
2022/05/10 | 4,110 | 4,185 | 4,055 | 4,140 | +20 | +0.5% | 149,100 |
2022/05/09 | 4,205 | 4,210 | 4,115 | 4,120 | -95 | -2.3% | 90,300 |
2022/05/06 | 4,200 | 4,230 | 4,155 | 4,215 | -10 | -0.2% | 147,300 |
2022/05/02 | 4,110 | 4,255 | 4,110 | 4,225 | -130 | -3% | 130,900 |
2022/04/28 | 4,245 | 4,355 | 4,225 | 4,355 | +90 | +2.1% | 80,900 |
2022/04/27 | 4,270 | 4,310 | 4,230 | 4,265 | -25 | -0.6% | 257,800 |
2022/04/26 | 4,270 | 4,310 | 4,270 | 4,290 | +20 | +0.5% | 61,400 |
2022/04/25 | 4,225 | 4,290 | 4,225 | 4,270 | -30 | -0.7% | 62,400 |
2022/04/22 | 4,270 | 4,310 | 4,250 | 4,300 | -25 | -0.6% | 49,100 |
2022/04/21 | 4,250 | 4,340 | 4,250 | 4,325 | +80 | +1.9% | 70,400 |
2022/04/20 | 4,195 | 4,250 | 4,175 | 4,245 | +100 | +2.4% | 84,800 |
2022/04/19 | 4,185 | 4,185 | 4,125 | 4,145 | -20 | -0.5% | 89,500 |
2022/04/18 | 4,205 | 4,220 | 4,110 | 4,165 | -75 | -1.8% | 92,500 |
2022/04/15 | 4,310 | 4,320 | 4,225 | 4,240 | -130 | -3% | 80,700 |
2022/04/14 | 4,290 | 4,390 | 4,290 | 4,370 | +50 | +1.2% | 97,600 |
2022/04/13 | 4,220 | 4,330 | 4,210 | 4,320 | +90 | +2.1% | 139,700 |
2022/04/12 | 4,290 | 4,305 | 4,190 | 4,230 | -55 | -1.3% | 124,700 |
2022/04/11 | 4,225 | 4,310 | 4,215 | 4,285 | +55 | +1.3% | 135,600 |
2022/04/08 | 4,200 | 4,255 | 4,140 | 4,230 | -210 | -4.7% | 357,200 |
2022/04/07 | 4,450 | 4,465 | 4,410 | 4,440 | -60 | -1.3% | 120,800 |
2022/04/06 | 4,560 | 4,570 | 4,490 | 4,500 | -40 | -0.9% | 51,900 |
2022/04/05 | 4,550 | 4,550 | 4,515 | 4,540 | +40 | +0.9% | 61,300 |
2022/04/04 | 4,545 | 4,545 | 4,480 | 4,500 | +10 | +0.2% | 47,200 |
2022/04/01 | 4,440 | 4,505 | 4,405 | 4,490 | +30 | +0.7% | 72,700 |
2022/03/31 | 4,500 | 4,520 | 4,455 | 4,460 | +5 | +0.1% | 105,500 |
601~
650
件表示中 / 893件
類似銘柄と比較する
現在ご覧いただいている「サワイGHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サワイGHD | 196,400円 | +4.0% | +25.4% | 2.70% | 9.07倍 | 1.19倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ペプチド | 272,300円 | +56.7% | +357.2% | 0.00% | 25.21倍 | 6.00倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 422,700円 | +5.9% | 0.0% | 2.93% | 9.49倍 | 1.21倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
住友ファーマ | 61,700円 | +7.5% | - | 0.00% | - | 2.15倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
科研薬 | 445,100円 | +22.8% | +113.0% | 4.27% | 11.87倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム